Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 single-arm nivolumab study in previously treated advanced squamous non-small cell lung cancer
2012-003965-16Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nivolumab in Pulmonary squamous cell carcinoma, sponsored by Bristol Myers Squibb. Primary endpoint: Objective response rate. Started Feb 2013; status: completed.
02
Drugs
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on 2012-003965-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003965-16.